ORMD-0801 QD + ORMD-0801 BD
Phase 3Terminated 0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Type 2 Diabetes Mellitus
Conditions
Type 2 Diabetes Mellitus
Trial Timeline
Dec 15, 2020 → Jan 13, 2023
NCT ID
NCT04606576About ORMD-0801 QD + ORMD-0801 BD
ORMD-0801 QD + ORMD-0801 BD is a phase 3 stage product being developed by Oramed Pharmaceuticals for Type 2 Diabetes Mellitus. The current trial status is terminated. This product is registered under clinical trial identifier NCT04606576. Target conditions include Type 2 Diabetes Mellitus.
What happened to similar drugs?
20 of 20 similar drugs in Type 2 Diabetes Mellitus were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04606576 | Phase 3 | Terminated |
Competing Products
20 competing products in Type 2 Diabetes Mellitus